Actos is a drug that has been used to treat Type-2 diabetes. Studies now indicate that Actos can cause serious injuries, including heart attack, heart failure, and an increased risk of bladder cancer.
As a result of a study linking Actos to bladder cancer, France withdrew Actos from the market in June 2011. Likewise, Germany, has advised doctors against prescribing the drug due to the increased risk of bladder cancer resulting from its use.
The Food and Drug Administration (FDA) has updated the warning label of Actos, announcing a link between the drug and increased risk of bladder cancer.
Many lawsuits have now been filed across the country regarding Actos. The Judicial Panel on Multidistrict Litigation (JPMDL) will hold a hearing in early December to determine if all Actos lawsuits should be consolidated in one federal court for discovery and pre-trial proceedings. A decision is expected in early 2012.
